• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Request Free Sample ×

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor
    Hero Background

    Arachidonic Acid Market

    ID: MRFR/CnM/21421-HCR
    111 Pages
    Pradeep Nandi
    October 2025

    Arachidonic Acid Market Research Report By Purity (95%, 98%, 99%), By Form (Liquid, Powder, Capsule), By Source (Plant-Based, Animal-Based, Synthetic), By Application (Pharmaceuticals, Dietary Supplements, Cosmetics, Food and Beverage), By Concentration (100 mg/ml, 200 mg/ml, 500 mg/ml) and By Regional (North America, Europe, South America, Asia-Pacific, Middle East and Africa) - Forecast to 2035

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Arachidonic Acid Market Infographic

    Arachidonic Acid Market Summary

    As per MRFR analysis, the Arachidonic Acid Market Size was estimated at 6.558 USD Billion in 2024. The Arachidonic Acid industry is projected to grow from 6.885 USD Billion in 2025 to 11.18 USD Billion by 2035, exhibiting a compound annual growth rate (CAGR) of 4.97 during the forecast period 2025 - 2035.

    Key Market Trends & Highlights

    The Arachidonic Acid Market is experiencing a dynamic shift driven by health trends and innovative applications.

    • Rising health consciousness among consumers is propelling the demand for arachidonic acid in nutritional supplements.
    • North America remains the largest market, while the Asia-Pacific region is emerging as the fastest-growing area for arachidonic acid applications.
    • The liquid segment dominates the market, whereas the powder segment is witnessing rapid growth due to its versatility.
    • Key drivers include the increasing demand for nutritional supplements and advancements in medical research, highlighting the importance of omega fatty acids.

    Market Size & Forecast

    2024 Market Size 6.558 (USD Billion)
    2035 Market Size 11.18 (USD Billion)
    CAGR (2025 - 2035) 4.97%

    Major Players

    BASF SE (DE), Cargill, Incorporated (US), FMC Corporation (US), Martek Biosciences Corporation (US), Omega Protein Corporation (US), Nutraceutical Corporation (US), DSM Nutritional Products (CH), Kemin Industries, Inc. (US)

    Arachidonic Acid Market Trends

    The Arachidonic Acid Market is currently experiencing a notable evolution, driven by increasing awareness regarding the health benefits associated with this polyunsaturated fatty acid. Arachidonic acid plays a crucial role in various physiological processes, including inflammation and immune response, which has led to its rising incorporation in dietary supplements and functional foods. As consumers become more health-conscious, the demand for products enriched with arachidonic acid appears to be on the rise, particularly among athletes and individuals seeking to enhance their overall well-being. Furthermore, the growing interest in personalized nutrition may further propel the market, as consumers seek tailored solutions to meet their specific health needs. In addition to dietary applications, the Arachidonic Acid Market is witnessing advancements in the pharmaceutical sector. Research indicates that arachidonic acid may have therapeutic potential in treating various conditions, including cardiovascular diseases and neurodegenerative disorders. This potential has attracted the attention of pharmaceutical companies, which are increasingly investing in the development of arachidonic acid-based therapies. Moreover, the trend towards plant-based diets is also influencing the market, as manufacturers explore alternative sources of arachidonic acid, such as algae and fungi, to cater to the growing vegan and vegetarian populations. Overall, the Arachidonic Acid Market is poised for growth, driven by diverse applications and evolving consumer preferences.

    Rising Health Consciousness

    The increasing awareness of health and wellness among consumers is driving the demand for arachidonic acid. This trend is particularly evident in the dietary supplement sector, where individuals seek products that support physical performance and overall health.

    Pharmaceutical Innovations

    The pharmaceutical industry is exploring the therapeutic potential of arachidonic acid, particularly in relation to chronic diseases. This trend suggests a growing interest in developing new treatments that leverage the properties of this fatty acid.

    Shift Towards Plant-Based Sources

    As more consumers adopt plant-based diets, there is a noticeable shift towards sourcing arachidonic acid from alternative sources. This trend indicates a response to the demand for vegan-friendly products, prompting manufacturers to innovate.

    The Global Arachidonic Acid Market appears to be experiencing a notable shift towards increased demand in the nutraceutical sector, driven by growing consumer awareness regarding health benefits and dietary supplementation.

    U.S. Department of Agriculture

    Arachidonic Acid Market Drivers

    Advancements in Medical Research

    Recent advancements in medical research have illuminated the potential therapeutic benefits of arachidonic acid, particularly in the context of inflammatory diseases and neurological disorders. The Arachidonic Acid Market is likely to benefit from these findings, as healthcare professionals increasingly recognize the importance of omega-6 fatty acids in managing various health conditions. Research indicates that arachidonic acid may play a crucial role in modulating inflammation, which could lead to its incorporation into treatment protocols. As a result, the demand for arachidonic acid in pharmaceutical applications is expected to rise, further propelling the growth of the Arachidonic Acid Market.

    Regulatory Support for Nutraceuticals

    The Arachidonic Acid Market is benefiting from favorable regulatory frameworks that support the development and marketing of nutraceuticals. Governments and health organizations are increasingly recognizing the importance of dietary supplements in promoting public health. This regulatory support is likely to encourage investment in research and development, leading to innovative products that incorporate arachidonic acid. As a result, the Arachidonic Acid Market may experience accelerated growth as companies capitalize on these opportunities to introduce new formulations that meet consumer demands for health-enhancing products.

    Rising Popularity of Sports Nutrition

    The Arachidonic Acid Market is witnessing a significant uptick in interest from the sports nutrition sector. Athletes and fitness enthusiasts are increasingly turning to arachidonic acid supplements to enhance performance and recovery. This trend is supported by market data, which suggests that the sports nutrition market is anticipated to grow at a CAGR of around 7% in the coming years. As more individuals engage in rigorous training regimens, the demand for products containing arachidonic acid is likely to increase, positioning the Arachidonic Acid Market favorably within the broader nutritional landscape.

    Growing Awareness of Omega Fatty Acids

    There is a rising awareness among consumers regarding the health benefits associated with omega fatty acids, particularly arachidonic acid. The Arachidonic Acid Market is poised to capitalize on this trend as educational campaigns and health initiatives promote the importance of these essential fatty acids in maintaining overall health. Market data suggests that the demand for omega-6 fatty acids is on the rise, with consumers increasingly seeking products that contain arachidonic acid for its potential benefits in cardiovascular health and inflammation management. This growing awareness is likely to drive the expansion of the Arachidonic Acid Market in the foreseeable future.

    Increasing Demand for Nutritional Supplements

    The Arachidonic Acid Market is experiencing a notable surge in demand for nutritional supplements, driven by a growing awareness of health and wellness among consumers. As individuals increasingly seek to enhance their dietary intake with essential fatty acids, arachidonic acid has gained prominence due to its role in muscle growth and recovery. Market data indicates that the dietary supplement sector is projected to expand at a compound annual growth rate (CAGR) of approximately 8% over the next five years. This trend suggests that the Arachidonic Acid Market could see substantial growth as manufacturers innovate and introduce new formulations that cater to health-conscious consumers.

    Market Segment Insights

    By Purity: 99% (Largest) vs. 95% (Emerging)

    In the Arachidonic Acid market, the distribution of purity levels reveals that the 99% purity segment holds the largest share, catering to a broad range of applications requiring high-quality Arachidonic Acid. The 98% purity segment closely follows, supported by its balance of quality and cost efficiency, while the 95% purity segment, while smaller, plays an important role in cost-sensitive applications. As the demand for higher purity levels continues to increase, the competitive landscape shifts accordingly, influencing formulations in dietary supplements, food products, and pharmaceuticals. The growth trends in the Purity segment are indicative of changing consumer preferences, particularly the growing demand for superior quality ingredients in health-related products. Factors such as the rise in health consciousness and the expanding application of Arachidonic Acid in functional foods and nutrition drive this trend. Furthermore, advancements in extraction and purification technologies are enabling manufacturers to produce higher purity Arachidonic Acid more efficiently, propelling the market towards an increasingly quality-focused standard.

    99% (Dominant) vs. 95% (Emerging)

    The 99% purity segment is recognized as the dominant force in the Arachidonic Acid market, primarily due to its essential role in high-end supplements and pharmaceuticals. This segment caters to an upscale market seeking quality without compromise. On the other hand, the 95% purity segment, while classified as emerging, remains crucial for cost-effective formulations catering to a wider audience. The emerging nature of the 95% segment is attributed to its ability to meet lower price points while still providing significant health benefits, making it particularly appealing for mainstream products. As innovation continues to enhance purification processes, both segments are likely to evolve, with the 99% segment leading in luxury and premium offerings and the 95% segment capturing value-driven consumers.

    By Form: Liquid (Largest) vs. Powder (Fastest-Growing)

    In the Arachidonic Acid Market, the form segment is primarily dominated by liquid formulations, which capture the largest share of market demand. Liquid forms are favored for their ease of incorporation into various products and applications, particularly in the dietary supplement and food industries. Powder formulations, while currently smaller in market share, showcase a growing interest among consumers seeking convenient alternatives for blending and encapsulation. The Arachidonic Acid Market is witnessing a significant increase in the adoption of powder forms, driven by their versatility and the rising popularity of functional food and supplement products. As consumers become more health-conscious and demand innovative nutritional sources, the powder segment is poised for rapid growth. This shift is further supported by advancements in processing technology that enhance the stability and efficacy of powdered Arachidonic Acid products.

    Liquid (Dominant) vs. Powder (Emerging)

    Liquid Arachidonic Acid formulations are characterized by their robust applicability in a range of dietary products, offering high bioavailability and ease of use. As the dominant form in the market, liquids cater to consumer preferences for immediate incorporation into functional foods and sports nutrition supplements. On the other hand, powder forms are emerging as a viable alternative, appealing to a segment of users who prioritize dosage flexibility and product customization. They are increasingly used in innovative formulations, aligning with trends towards personalized nutrition. While liquid maintains a solid foothold, the emergence of powdered forms signifies a shift in consumer preferences, showcasing the industry's adaptability to diverse market demands.

    By Source: Plant-Based (Largest) vs. Animal-Based (Fastest-Growing)

    The Arachidonic Acid Market is notably segmented by source, with the plant-based segment capturing the largest market share. This segment is increasingly favored due to rising consumer awareness regarding plant-based diets and healthier lifestyle choices. As a result, manufacturers are increasingly focusing on sourcing Arachidonic Acid from plant origins, leveraging the growing trend towards sustainability and environmental consciousness. In contrast, the animal-based segment, although smaller, is witnessing rapid growth. This is driven by the increasing demand for natural sources of Arachidonic Acid, commonly found in animal tissues and products, appealing primarily to health-conscious consumers and athletes needing enhanced performance. Growth trends within the Arachidonic Acid Market signify a positive outlook for both segments, irrespective of market share differences. Plant-based sources boast a steady rise, fueled by the global trend transitioning towards plant-based nutrition. Meanwhile, the animal-based segment is positioned for significant growth driven by the increasing recognition of the nutritional benefits Arachidonic Acid provides, particularly for brain function and inflammatory response. Additionally, synthetic sources are progressively gaining acceptance but still lag in market share, as consumers are gravitating towards more natural products. Overall, the Arachidonic Acid Market's source segment is at a turning point, catering to evolving dietary preferences.

    Source: Plant-Based (Dominant) vs. Animal-Based (Emerging)

    The plant-based source of Arachidonic Acid is currently dominant within the market due to its alignment with contemporary health trends and sustainability practices. Derived from algae and other vegetation, plant-based Arachidonic Acid appeals to vegan and vegetarian demographics and presents fewer ethical concerns compared to animal sources. This segment is highly adaptable and is utilized in various applications, from supplements to functional foods. On the flip side, the animal-based source of Arachidonic Acid is emerging robustly as consumers begin to recognize its high bioavailability and efficacy, particularly in formulations targeting muscle health and cognitive function. Sourced from eggs and meat, this segment appeals primarily to consumers seeking powerful dietary sources for health optimization. The interplay between these sources highlights a dynamic market landscape where consumer preferences are rapidly evolving.

    By Application: Pharmaceuticals (Largest) vs. Dietary Supplements (Fastest-Growing)

    In the Arachidonic Acid Market, the application segments exhibit distinct characteristics and share distributions. The Pharmaceuticals segment stands as the largest contributor to market share, driven by the increasing demand for therapeutic applications of arachidonic acid. Pharmaceuticals leverage its anti-inflammatory properties, resulting in significant market penetration. Conversely, the Dietary Supplements segment is recognized as the fastest-growing sector, fueled by rising health consciousness and a consumer shift towards preventive healthcare solutions. This segment harnesses the nutritional benefits of arachidonic acid, propelling its demand in various dietary formulations.

    Pharmaceuticals (Dominant) vs. Dietary Supplements (Emerging)

    The Pharmaceuticals segment of the Arachidonic Acid Market is characterized by its strong regulatory framework and established presence in therapeutic applications. It primarily serves the production of anti-inflammatory medications, emphasizing the efficacy and safety of arachidonic acid in medical treatments. This dominant segment benefits from continuous R&D investment, leading to innovative pharmaceutical formulations. In contrast, the Dietary Supplements segment is emerging rapidly, driven by demographic shifts and increased awareness of health benefits associated with natural ingredients. This segment attracts a diverse consumer base, including fitness enthusiasts and aging populations seeking to enhance their overall well-being through nutritional supplementation of arachidonic acid.

    By Concentration: 500 mg/ml (Largest) vs. 200 mg/ml (Fastest-Growing).webp

    In the Arachidonic Acid market, concentration levels are critical for various applications, categorizing products into 100 mg/ml, 200 mg/ml, and 500 mg/ml. Presently, the 500 mg/ml concentration occupies the largest share, catering to sectors that demand higher potency. The 200 mg/ml concentration, while smaller in share, is rapidly gaining traction due to its balanced efficacy and ease of use, making it favorable among new entrants in the market.

    Concentration: 500 mg/ml (Dominant) vs. 200 mg/ml (Emerging)

    The 500 mg/ml concentration is recognized for its robustness and is widely utilized in medical and nutritional formulations that require potent doses. Its dominance in the market is propelled by its effectiveness in clinical applications and research. Meanwhile, the 200 mg/ml concentration is emerging as a versatile option, appealing to smaller manufacturers and health enthusiasts. This segment benefits from increasing awareness of optimal dosing and personalized nutrition, positioning it as a key player in the evolving landscape of the Arachidonic Acid market.

    Get more detailed insights about Arachidonic Acid Market

    Regional Insights

    North America : Innovation and Demand Surge

    North America is the largest market for arachidonic acid, holding approximately 45% of the global share. The region's growth is driven by increasing demand in the dietary supplement and infant nutrition sectors, alongside stringent regulatory frameworks that promote product safety and efficacy. The presence of major players like Cargill and BASF further fuels market expansion, supported by rising health consciousness among consumers. The United States dominates the North American market, accounting for the majority of sales, followed by Canada. The competitive landscape is characterized by significant investments in R&D and strategic partnerships among key players. Companies are focusing on innovative formulations and sustainable sourcing to meet consumer demands, ensuring a robust market presence in this region.

    Europe : Regulatory Framework and Growth

    Europe is witnessing significant growth in the arachidonic acid market, holding around 30% of the global share. The region's expansion is driven by increasing awareness of health benefits associated with arachidonic acid, particularly in infant nutrition and dietary supplements. Regulatory bodies are actively promoting the safe use of these products, which enhances consumer trust and market growth. The European Food Safety Authority (EFSA) plays a crucial role in establishing guidelines that support market development. Leading countries in Europe include Germany, France, and the UK, which are home to several key players like DSM Nutritional Products and Kemin Industries. The competitive landscape is marked by innovation and collaboration among companies to develop high-quality products. As consumer preferences shift towards natural and organic options, the market is adapting to meet these demands, ensuring sustained growth in the region.

    Asia-Pacific : Rapid Growth and Opportunities

    Asia-Pacific is rapidly emerging as a significant player in the arachidonic acid market, holding approximately 20% of the global share. The region's growth is fueled by rising disposable incomes, increasing health awareness, and a growing population that demands nutritional products. Countries like China and India are leading this growth, supported by favorable government policies that encourage the development of health supplements and functional foods. China is the largest market in the region, followed by India and Japan. The competitive landscape is evolving, with both local and international players vying for market share. Companies are focusing on product innovation and expanding distribution channels to cater to the growing consumer base. The presence of key players like Omega Protein Corporation and Martek Biosciences enhances the market's competitive dynamics, driving further growth in this region.

    Middle East and Africa : Untapped Market Potential

    The Middle East and Africa region is gradually emerging in the arachidonic acid market, currently holding about 5% of the global share. The growth is primarily driven by increasing health awareness and a rising demand for nutritional supplements among the growing population. Governments are beginning to recognize the importance of dietary supplements, leading to more supportive regulations that encourage market growth and consumer safety. Countries like South Africa and the UAE are at the forefront of this market, with increasing investments in health and wellness sectors. The competitive landscape is characterized by a mix of local and international players, with companies focusing on product diversification and marketing strategies to capture the growing consumer interest. As the market matures, opportunities for growth and expansion are becoming more apparent, making this region a potential hotspot for arachidonic acid products.

    Key Players and Competitive Insights

    The Arachidonic Acid Market is currently characterized by a dynamic competitive landscape, driven by increasing demand for nutritional supplements and functional foods. Key players such as BASF SE (Germany), Cargill, Incorporated (US), and DSM Nutritional Products (Switzerland) are strategically positioned to leverage their extensive research and development capabilities. These companies are focusing on innovation and product differentiation to capture market share, while also exploring partnerships and acquisitions to enhance their operational efficiencies. The collective strategies of these firms contribute to a moderately fragmented market structure, where competition is intensifying as companies seek to establish a foothold in emerging markets.

    In terms of business tactics, companies are increasingly localizing manufacturing to reduce costs and improve supply chain resilience. This approach not only enhances their ability to respond to regional demand fluctuations but also aligns with sustainability goals. The market structure remains moderately fragmented, with several players vying for dominance. The influence of major companies is significant, as they set trends in product development and market strategies, thereby shaping the overall competitive environment.

    In August 2025, BASF SE (Germany) announced the launch of a new line of Arachidonic Acid-based products aimed at the infant nutrition sector. This strategic move is particularly noteworthy as it aligns with the growing consumer preference for specialized nutritional products. By targeting this niche market, BASF SE is likely to enhance its competitive edge and expand its market presence, capitalizing on the increasing awareness of the importance of Arachidonic Acid in early development.

    In September 2025, Cargill, Incorporated (US) revealed a partnership with a leading biotechnology firm to develop sustainable sources of Arachidonic Acid. This collaboration underscores Cargill's commitment to sustainability and innovation, as it seeks to address the rising consumer demand for environmentally friendly products. The strategic importance of this partnership lies in its potential to position Cargill as a leader in sustainable Arachidonic Acid production, thereby appealing to a growing segment of eco-conscious consumers.

    In July 2025, DSM Nutritional Products (Switzerland) expanded its production capabilities by investing in a new facility dedicated to the production of Arachidonic Acid. This investment reflects DSM's focus on meeting the increasing global demand for high-quality nutritional ingredients. The strategic significance of this expansion is multifaceted; it not only enhances DSM's production capacity but also reinforces its commitment to quality and innovation in the nutritional sector.

    As of October 2025, the Arachidonic Acid Market is witnessing trends that emphasize digitalization, sustainability, and the integration of artificial intelligence in production processes. Strategic alliances are becoming increasingly prevalent, as companies recognize the value of collaboration in navigating complex market dynamics. Looking ahead, competitive differentiation is expected to evolve, shifting from traditional price-based competition to a focus on innovation, technological advancements, and supply chain reliability. This transition may redefine the competitive landscape, compelling companies to adapt and innovate continuously.

    Key Companies in the Arachidonic Acid Market market include

    Industry Developments

    • Q2 2024: FDA Approves Expanded Label for Baxter’s Lipid Injectable Emulsion to Include Preterm and Term Neonates In May 2024, the FDA expanded the label for Baxter's lipid injectable emulsion, which contains arachidonic acid, to include use in preterm and term neonates, enhancing nutritional options for pediatric patients requiring parenteral nutrition.[3]

    Future Outlook

    Arachidonic Acid Market Future Outlook

    The Arachidonic Acid Market is projected to grow at a 4.97% CAGR from 2024 to 2035, driven by increasing demand in pharmaceuticals, dietary supplements, and infant nutrition.

    New opportunities lie in:

    • Expansion into emerging markets with tailored product offerings.
    • Development of innovative delivery systems for enhanced bioavailability.
    • Strategic partnerships with health-focused brands for co-marketing initiatives.

    By 2035, the Arachidonic Acid Market is expected to achieve robust growth and increased market penetration.

    Market Segmentation

    Arachidonic Acid Market Form Outlook

    • Liquid
    • Powder
    • Capsule

    Arachidonic Acid Market Purity Outlook

    • 95%
    • 98%
    • 99%

    Arachidonic Acid Market Source Outlook

    • Plant-Based
    • Animal-Based
    • Synthetic

    Arachidonic Acid Market Application Outlook

    • Pharmaceuticals
    • Dietary Supplements
    • Cosmetics
    • Food and Beverage

    Arachidonic Acid Market Concentration Outlook

    • 100 mg/ml.webp
    • 200 mg/ml.webp
    • 500 mg/ml.webp

    Report Scope

    MARKET SIZE 20246.558(USD Billion)
    MARKET SIZE 20256.885(USD Billion)
    MARKET SIZE 203511.18(USD Billion)
    COMPOUND ANNUAL GROWTH RATE (CAGR)4.97% (2024 - 2035)
    REPORT COVERAGERevenue Forecast, Competitive Landscape, Growth Factors, and Trends
    BASE YEAR2024
    Market Forecast Period2025 - 2035
    Historical Data2019 - 2024
    Market Forecast UnitsUSD Billion
    Key Companies ProfiledMarket analysis in progress
    Segments CoveredMarket segmentation analysis in progress
    Key Market OpportunitiesGrowing demand for Arachidonic Acid in infant nutrition and dietary supplements presents significant market opportunities.
    Key Market DynamicsRising demand for arachidonic acid in infant nutrition drives innovation and competition among manufacturers.
    Countries CoveredNorth America, Europe, APAC, South America, MEA

    Leave a Comment

    FAQs

    What is the current valuation of the Arachidonic Acid Market as of 2024?

    The Arachidonic Acid Market was valued at 6.558 USD Billion in 2024.

    What is the projected market size for the Arachidonic Acid Market in 2035?

    The market is projected to reach 11.18 USD Billion by 2035.

    What is the expected CAGR for the Arachidonic Acid Market during the forecast period 2025 - 2035?

    The expected CAGR for the Arachidonic Acid Market during 2025 - 2035 is 4.97%.

    Which companies are considered key players in the Arachidonic Acid Market?

    Key players include BASF SE, Cargill, Incorporated, FMC Corporation, and others.

    What are the projected valuations for different purity segments of Arachidonic Acid?

    Projected valuations for purity segments are 2.5 to 4.2 USD Billion for 95%, 2.0 to 3.4 USD Billion for 98%, and 2.058 to 3.558 USD Billion for 99%.

    How does the market segment by form, and what are the projected valuations?

    The market segments by form include Liquid (2.5 to 4.2 USD Billion), Powder (2.0 to 3.2 USD Billion), and Capsule (2.058 to 3.748 USD Billion).

    What are the projected valuations for Arachidonic Acid based on source?

    The projected valuations based on source are 1.5 to 2.5 USD Billion for Plant-Based, 2.5 to 4.0 USD Billion for Animal-Based, and 2.558 to 4.68 USD Billion for Synthetic.

    What applications are driving the Arachidonic Acid Market, and what are their projected valuations?

    Applications driving the market include Pharmaceuticals (2.5 to 4.2 USD Billion), Dietary Supplements (1.5 to 2.5 USD Billion), and Cosmetics (1.0 to 1.8 USD Billion).

    What are the projected valuations for different concentrations of Arachidonic Acid?

    Projected valuations for concentrations are 1.5 to 2.5 USD Billion for 100 mg/ml, 2.5 to 4.0 USD Billion for 200 mg/ml, and 2.558 to 4.68 USD Billion for 500 mg/ml.

    How does the Arachidonic Acid Market's growth potential appear in comparison to other markets?

    The Arachidonic Acid Market's growth potential appears robust, with a projected CAGR of 4.97% from 2025 - 2035.

    Download Free Sample

    Kindly complete the form below to receive a free sample of this Report

    Case Study
    Chemicals and Materials

    Compare Licence

    ×
    Features License Type
    Single User Multiuser License Enterprise User
    Price $4,950 $ $7,250
    Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
    Free Customization
    Direct Access to Analyst
    Deliverable Format
    Platform Access
    Discount on Next Purchase 10% 15% 15%
    Printable Versions